As shown in Figure 1b, these CD34+/CD38− leukemia stem-like cells displayed positivity of the myeloid markers CD13 (99.1%), CD33 (98.6%), and CD123 (93.7%), suggesting that certain myeloid features remain in these sorted CD34+/CD38− KG1α cells. This evidence concerns the gene CD34 and leukemia.